accountpromises to increase the cure rate while shortening the time required for treatment. The new drug, Victrelis from Merck, effectively cured more than 60 percent of patients in clinical trials when used along with existing drugs. That compared with 20 to...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Merck���s Hepatitis C Drug Wins F.D.A. Approval
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account